Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Effect of atypical antipsychotics on fetal growth: is the placenta involved?

Raha S, Taylor VH, Holloway AC.

J Pregnancy. 2012;2012:315203. doi: 10.1155/2012/315203. Epub 2012 Jul 11. Review.

2.

Antipsychotic use in pregnancy.

Kulkarni J, Storch A, Baraniuk A, Gilbert H, Gavrilidis E, Worsley R.

Expert Opin Pharmacother. 2015 Jun;16(9):1335-45. doi: 10.1517/14656566.2015.1041501. Review.

PMID:
26001182
3.

Clinical utilization of atypical antipsychotics in pregnancy and lactation.

Gentile S.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1265-71. Epub 2004 May 18. Review.

PMID:
15150376
4.

Increasing use of atypical antipsychotics and anticonvulsants during pregnancy.

Epstein RA, Bobo WV, Shelton RC, Arbogast PG, Morrow JA, Wang W, Chandrasekhar R, Cooper WO.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):794-801. doi: 10.1002/pds.3366. Epub 2012 Nov 5.

5.

Significant changes in antipsychotic drug use during pregnancy.

McKenna K, Einarson A, Levinson A, Gideon K.

Vet Hum Toxicol. 2004 Feb;46(1):44-6.

PMID:
14748418
6.

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A.

J Clin Psychiatry. 2005 Apr;66(4):444-9; quiz 546.

PMID:
15816786
7.

Cadmium-induced teratogenicity: association with ROS-mediated endoplasmic reticulum stress in placenta.

Wang Z, Wang H, Xu ZM, Ji YL, Chen YH, Zhang ZH, Zhang C, Meng XH, Zhao M, Xu DX.

Toxicol Appl Pharmacol. 2012 Mar 1;259(2):236-47. doi: 10.1016/j.taap.2012.01.001. Epub 2012 Jan 9.

PMID:
22252055
8.

Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.

Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, Knight BT, Gibson BB, Viguera AC, Owens MJ, Nemeroff CB, Stowe ZN.

Am J Psychiatry. 2007 Aug;164(8):1214-20.

PMID:
17671284
9.

Maternal dietary omega-3 fatty acid supplementation reduces placental oxidative stress and increases fetal and placental growth in the rat.

Jones ML, Mark PJ, Mori TA, Keelan JA, Waddell BJ.

Biol Reprod. 2013 Feb 14;88(2):37. doi: 10.1095/biolreprod.112.103754. Print 2013 Feb.

PMID:
23269667
10.

Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study.

Newham JJ, Thomas SH, MacRitchie K, McElhatton PR, McAllister-Williams RH.

Br J Psychiatry. 2008 May;192(5):333-7. doi: 10.1192/bjp.bp.107.041541. Erratum in: Br J Psychiatry. 2008 Jun;192(6):477.

12.

The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.

Wang JS, Newport DJ, Stowe ZN, Donovan JL, Pennell PB, DeVane CL.

Drug Metab Rev. 2007;39(4):723-46. Review.

PMID:
18058331
13.

Fetal antipsychotic exposure in a changing landscape: seeing the future.

Abel KM.

Br J Psychiatry. 2013 May;202(5):321-3. doi: 10.1192/bjp.bp.112.117556.

14.

Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.

Jansson T, Powell TL.

Clin Sci (Lond). 2007 Jul;113(1):1-13. Review.

PMID:
17536998
15.

Maternal mental disorders and pregnancy outcomes: a clinical study in a Japanese population.

Hironaka M, Kotani T, Sumigama S, Tsuda H, Mano Y, Hayakawa H, Tanaka S, Ozaki N, Tamakoshi K, Kikkawa F.

J Obstet Gynaecol Res. 2011 Oct;37(10):1283-9. doi: 10.1111/j.1447-0756.2010.01512.x. Epub 2011 May 3.

PMID:
21535304
16.

Managing Your Own Mood Lability: Use of Mood Stabilizers and Antipsychotics in Pregnancy.

Wichman CL.

Curr Psychiatry Rep. 2016 Jan;18(1):1. doi: 10.1007/s11920-015-0646-1. Review.

PMID:
26685903
17.

Psychotropic drug use during pregnancy: weighing the risks.

Cohen LS, Rosenbaum JF.

J Clin Psychiatry. 1998;59 Suppl 2:18-28. Review.

18.

Use of antipsychotics in the management of schizophrenia during pregnancy.

Trixler M, Gáti A, Fekete S, Tényi T.

Drugs. 2005;65(9):1193-206. Review.

PMID:
15916447
19.

Agonist of farnesoid X receptor protects against bile acid induced damage and oxidative stress in mouse placenta--a study on maternal cholestasis model.

Wu WB, Xu YY, Cheng WW, Wang YX, Liu Y, Huang D, Zhang HJ.

Placenta. 2015 May;36(5):545-51. doi: 10.1016/j.placenta.2015.02.005. Epub 2015 Feb 17.

PMID:
25747729
20.

Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth.

Rosario FJ, Schumacher MA, Jiang J, Kanai Y, Powell TL, Jansson T.

J Physiol. 2012 Mar 15;590(6):1495-509. doi: 10.1113/jphysiol.2011.226399. Epub 2012 Jan 30.

Supplemental Content

Support Center